gemtuzumab ozogamicin
UCB Pharmaceuticals,pfizer
['gemtuzumab', 'bet', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', '2019', 'mds', 'valent ,(-prevalent)']
congress | #ash22 dr. sylvie freeman, presents results from the ncri aml18 trial. fractionated schedule of gemtuzumab ozogamicin was associated with a greater reduction of mrd and improved overall survival compared to single-dose gemtuzumab ozogamicin. #leusm 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm